Replies to post #23857 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

mcd2dinga stated: "The Inverness milestone payment is due or must be notified of intent in the November/December time frame. This could still happen before the new shares are placed. If this works out in BOCX's favor, BOCX could raise the funds needed at a higher share price and not place all of the authorized shares."


If Inverness does not return RECAF by November 4th, they would be obligated to pay the minimum royalty. That would certainly relieve some doubts that Inverness was going to return the product. One note of caution. Abbott had passed the date to pay the 2008 minimum royalty but that was forgiven in the amended agreement and never paid.

The number of shares used to raise $6.6 million does indeed depend upon the discount to the current market price at the time of the public offering. The higher the price, of course the less dilution. What should concern you is the shorting of the stock back down to the 14 cent area of Smithlines note conversion price. If that continues, the discount to market could incur substantial dilution.

[Gold Seeker]

mcd2dinga stated: "I have to say that, IMO, I do agree with other posters that you have gone from seeing all positives with BOCX to seeing all negatives. You do develop theories which you present as the only possible explanation. Lately, they always emphasize the nagative.
That's just how I see it."

Again, I will relate my thoughts on RECAF. Back in 2007 I began communicating with Moro and my posting was influenced by what he said. I had positive prospects for RECAF but still held a small number of shares at that time. When I discovered Abbott was presenting at the 2007 ISOBM, I made substantial purchases thinking Abbott would proceed. It was a gamble and I lost. I have no one to blame for that but myself.

After Abbott ceased working on RECAF, I quickly decided to see how many others actually thought universal cancer markers had any merit and if that was the reason for the Abbott amendment. It was that point that I discovered that two other universal markers had gone exactly nowhere in the market place. I was still hoping for the best but when the stock plunged, I sold.

From the point of the Abbott amendment and the stock price plunge, I have found nothing positive on RECAF or a universal marker. That is just a fact.

[Righteous Brother]

Authorizing shares is not the same as placing and selling. My guess is he is just going to sell a portion, then reserve the sale of additonal shares for a later date when the value of the shares are more in line with the true value of the technology. He probably will sell shares following a positive update to shareholders. I doubt if he sells at .15.